research
human
pathogen
often
hamper
lack
appropri
anim
model
recapitul
normal
infect
cycl
pathogenesi
mani
human
pathogen
show
preferenti
often
exclus
tropism
human
cell
replic
experiment
anim
issu
wahl
et
provid
mous
model
studi
respiratori
pathogen
lead
caus
death
infecti
diseas
global
fourth
common
caus
death
overal
mice
carri
human
fetal
lung
tissu
human
immun
system
allow
studi
pathogen
replic
human
cell
respiratori
tract
human
immun
respons
pathogen
anim
model
especi
suit
investig
pathogen
target
cell
lower
respiratori
tract
particularli
pathogen
relev
anim
model
exist
human
cytomegaloviru
hcmv
replic
human
wahl
et
build
decad
work
develop
immunodefici
mice
allow
engraft
human
immun
cell
tissu
fig
sever
mous
strain
avail
support
engraft
human
umbil
cord
blood
mobil
blood
bone
marrow
fetal
tissu
liver
human
hematopoiet
stem
cell
typic
engraft
strain
lack
inactiv
mutat
gene
requir
rearrang
cell
b
cell
receptor
gene
eg
recombinas
activ
gene
rag
dnadepend
serinethreonin
protein
kinas
prkdc
common
chain
interleukin
il
receptor
critic
develop
natur
killer
cell
strain
lack
mous
cell
b
cell
innat
lymphoid
cell
includ
natur
killer
cell
frequent
use
strain
also
use
wahl
et
nonobes
combin
immunodefici
nodscid
strain
prkdc
mutat
defici
call
nsg
mice
highli
immunodefici
strain
serv
creat
two
type
mice
human
immun
system
human
immun
system
mice
gener
simpli
inject
mice
human
hematopoiet
stem
mice
human
cell
develop
mous
thymu
bone
blt
complex
model
requir
transplant
human
fetal
liver
thymu
kidney
capsul
follow
inject
bone
marrow
hematopoiet
stem
cell
donor
presenc
human
liver
sourc
stem
cell
thymu
blt
mice
support
robust
cell
develop
observ
mice
wherea
coinject
hematopoiet
stem
cell
optim
develop
b
cell
hematopoiet
cell
blt
mice
cell
differ
human
hematopoiet
lineag
includ
b
cell
cell
present
primari
secondari
lymphoid
organ
well
peripher
excel
model
studi
humanspecif
pathogen
target
hematopoiet
cell
human
immunodefici
viru
viru
human
tcell
leukemia
viru
studi
pathogen
infect
nonhematopoiet
cell
research
transplant
human
tissu
along
hematopoiet
cell
exampl
mice
engraft
human
immun
cell
human
hepatocyt
hishuhep
mice
use
studi
immun
reaction
human
liver
trophic
virus
like
hepat
b
new
studi
wahl
et
substanti
extend
number
human
pathogen
model
human
mice
author
first
transplant
piec
human
fetal
lung
subcutan
back
nsg
mice
creat
human
lungonli
lom
mice
use
eleg
technolog
call
acoust
angiographi
demonstr
occurr
activ
angiogenesi
around
implant
interestingli
although
lung
implant
ectop
therefor
ventil
structur
featur
highli
similar
normal
human
lung
includ
ciliat
epithelium
alveolar
structur
blood
vessel
cartilag
wahl
et
show
graft
support
robust
replic
clinic
relev
human
respiratori
pathogen
limit
tropism
nonhuman
cell
middl
east
respiratori
coronaviru
zika
viru
respiratori
syncyti
viru
risk
human
health
global
author
also
studi
mycobacterium
bovi
bacillu
use
vaccin
tuberculosi
moreov
author
measur
express
viral
gene
lytic
replic
hcmv
vivo
first
time
lom
mice
lack
immun
system
pathogen
replic
uncontrol
mimic
infect
occur
healthi
human
author
continu
remark
studi
combin
lom
blt
model
creat
mice
lung
transplant
immun
system
call
bltl
mice
nsg
mice
first
transplant
human
fetal
liver
thymu
kidney
capsul
follow
implant
autolog
lung
tissu
final
inject
autolog
liverderiv
hematopoiet
stem
cell
level
repopul
human
hematopoiet
cell
outsid
lung
transplant
robust
bltl
blt
mice
lung
graft
also
substanti
popul
human
immun
cell
whether
popul
present
lung
graft
implant
whether
deriv
inject
hematopoiet
cell
unclear
cell
rel
proport
cell
cell
tissueresid
memori
recapitul
hematopoiet
cell
popul
human
lung
author
provid
convinc
evid
immun
respons
hcmv
bltl
mice
function
control
viral
replic
plasma
level
pro
antiinflammatori
cytokin
includ
coloni
stimul
factor
gmcsf
chemokin
protein
increas
infect
indic
ongo
immun
respons
adapt
immun
respons
mice
includ
antigenspecif
cytokineproduc
cell
virusspecif
antibodi
hcmvreactiv
immunoglobulin
detect
day
primari
infect
class
switch
hcmvspecif
immunoglobulin
g
observ
upon
singl
exposur
detect
nearli
mice
reexpos
hcmv
wahl
et
investig
whether
affin
matur
hcmvspecif
igg
mice
support
somat
hypermut
would
repres
import
advanc
thu
far
highaffin
classswitch
antigenspecif
antibodi
rare
produc
human
mous
model
sever
possibl
reason
one
host
strain
blt
mice
secondari
lymph
node
owe
lack
lymphoid
tissu
induc
cell
anoth
suboptim
interact
b
cell
cell
caus
lack
crossreact
part
critic
cytokin
involv
interact
also
nonhematopoiet
cell
import
b
cell
matur
mous
origin
appropri
interact
matur
b
cell
may
also
reason
lack
structur
germin
center
immun
blt
mice
import
analyz
b
cell
respons
bltl
mice
detail
mice
inde
gener
classswitch
also
affinitymatur
antibodi
util
would
greatli
enhanc
instanc
would
allow
test
new
vaccin
strategi
antivir
drug
antibiot
would
also
possibl
gener
broadli
react
highli
neutral
antibodi
clinic
relev
pathogen
virus
